vimarsana.com
Home
Live Updates
N-Acetyl-L-Leucine Granted Priority Review for Niemann-Pick Disease Type C : vimarsana.com
N-Acetyl-L-Leucine Granted Priority Review for Niemann-Pick Disease Type C : vimarsana.com
N-Acetyl-L-Leucine Granted Priority Review for Niemann-Pick Disease Type C
The FDA has accepted for Priority Review the New Drug Application for IB1001 for the treatment of Niemann-Pick disease type C.
Related Keywords
Mallory Factor ,
Drug Administration ,
Priority Review ,
New Drug Application ,
Prescription Drug User Fee Act ,